BioCardia, Inc.BioCardia, Inc.BioCardia, Inc.

BioCardia, Inc.

No trades
See on Supercharts
Market capitalization
‪9.99 M‬USD
−0.5481USD
‪−11.57 M‬USD
‪477.00 K‬USD
‪17.19 M‬
Beta (1Y)
1.68

About BioCardia, Inc.

CEO
Peter Alan Altman
Headquarters
Sunnyvale
Employees (FY)
20
Founded
1994
ISIN
US09060U5074
FIGI
BBG000BTJTF3
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BCDA is 0.37 USD — it has decreased by 4.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioCardia, Inc. stocks are traded under the ticker BCDA.
BioCardia, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
BCDA earnings for the last quarter are −0.12 USD whereas the estimation was −0.12 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.08 USD. See more details about BioCardia, Inc. earnings.
BioCardia, Inc. revenue for the last quarter amounts to ‪357.00 K‬ USD despite the estimated figure of ‪50.00 K‬ USD. In the next quarter revenue is expected to reach ‪190.00 K‬ USD.
Yes, you can track BioCardia, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BCDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioCardia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BCDA reached its all-time high on Feb 23, 2000 with the price of 5233.45 USD, and its all-time low was 0.36 USD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 20.00 employees. See our rating of the largest employees — is BioCardia, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioCardia, Inc. EBITDA is ‪−11.23 M‬ USD, and current EBITDA margin is ‪−2.35 K‬%. See more stats in BioCardia, Inc. financial statements.